Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Chemical brain scans may help reassure brain tumor patients

04.05.2004


’Chemical thumbprint’ can help determine if tumor is returning or dying

Brain tumor survivors live with the constant worry that their cancer might come back. And even if they have a brain scan every few months to check, doctors often can’t tell the difference between new cancer growth and tissue changes related to their treatment with radiation or chemotherapy.

That leaves patients with a tricky choice. Do they wait and watch? Let doctors take a brain biopsy? Or, in some cases, endure another brutal round of treatment just in case the tumor has returned?



But a new University of Michigan study shows that a relatively new kind of brain scan may give these patients the reassurance -- or early warning -- that they can’t get from the usual scans. U-M radiologists will present the evidence today at the annual meeting of the American Roentgen Ray Society, a major radiology organization.

The approach is called 2D CSI MRS, short for two-dimensional chemical shift imaging magnetic resonance spectroscopy. It allows doctors to non-invasively detect the levels of certain chemicals in brain tissue. Using the relative quantities of these chemicals, doctors can tell what’s really going on near a tumor’s original location.

The U-M Health System neuroradiology team will show that they have successfully developed a way to use the technique so that, in the vast majority of cases, they can tell the difference between recurring tumor, normal tissue, and tissue that’s inflamed or dying because of successful treatment.

"Using 2D CSI is like making a chemical thumbprint of the tumor and the surrounding tissue, and we can use the unique readings from various areas to determine what’s cancerous, and what’s treatment-related change," says Patrick Weybright, M.D., the U-M radiology resident who will present the results. "This allows us to give the patient earlier and more accurate information on what’s happening in their brain at a molecular level."

Weybright will show results from 29 patients ages four years to 54 years, who were split almost evenly between those whose cancer had returned, and those with no recurrence. In addition to the biopsy or surgery that verified their status, nearly all of them had the 2D CSI type of scan, also called a multi-voxel scan. One had a less sophisticated single-voxel chemical scan. All the patients also had conventional diagnostic imaging with MRI scans to show brain tissue and tumor structure.

"In all, we were able to show a significant difference in chemical ratios for those who had treatment-related changes and those who had recurrent tumor," says senior study author Pia Maly Sundgren, M.D., Ph.D., associate professor of radiology.

"This, combined with conventional MRI and clinical indicators, should help increase the accuracy of diagnosis, make diagnosis more timely, and improve the quality of life for patients," Sundgren continues. "And helping them have a better life is the ultimate goal."

The U-M researchers are looking forward to the arrival of advanced three-Tesla MRI scanners that will increase their ability to look for more chemicals on the 2D CSI scans, and allow them to do three-dimensional scans that will increase accuracy even more.

But at the same time, they hope their results will help physicians and insurance companies see the true clinical value of 2D CSI MRS, which is still not universally covered by health plans in an amount sufficient to cover the time needed to read the scans.

Single-voxel CSI MRS -- more common, but less exhaustive, than the 2D multi-voxel approach -- is routinely used to evaluate patients with strokes, oxygen deprivation, epilepsy, multiple sclerosis, and other brain disorders. It is also used to determine the grade of brain tumors.

Both single-voxel and multi-voxel spectroscopy techniques add far more information to the diagnostic process than a regular MRI, which uses an injected dye and a strong magnetic field to make a grayscale picture of brain tissue structure based on the chemical signal of water molecules.

The MRI dye, also called a contrast agent, helps radiologists see finer details of the tissue structure more clearly. But because regular MRI doesn’t reveal anything about what’s going on inside those tissues at a molecular level, the "contrast-enhanced" areas that look suspicious on an MRI of a brain tumor survivor’s brain might be either dying tissue or growing tumor.

But the multi-voxel 2D CSI MRS scans, made using the same MRI equipment, produce line graphs with peaks that correspond to the levels of certain chemicals in various areas around the tumor.

The spikes on the graphs reveal the relative concentrations of chemicals that are produced or used up by growing cancers or dying cells. Depending on which area of the brain is scanned, those concentrations might be high or low. And, the U-M team shows, by making a ratio between the levels of two chemicals, it’s possible to show clear differences between different kinds of tissue.

Some of the chemicals studied in the new U-M research include N-acetylaspartate, or NAA, a chemical that’s produced by normal brain cells; lactate, produced by cells that have been starved of oxygen; choline, which marks an area of rapidly dividing or growing cells; and creatine, which serves as an internal control molecule.

The U-M team showed that the ratios of choline to creatine, of NAA to creatine, and of choline to NAA, were significantly different in normal tissue, versus recurrent tumor or treatment-altered tissue. For example, the choline/creatine ratio for recurrent tumor tissue was 2.30, while normal tissue had a ratio of 1.02 and tissue with treatment-related changes was 1.56.

They also showed they were able to avoid one of the biggest pitfalls of 2D CSI MRS, an effect known as "susceptibility artifact" that occurs when bone, sinuses or other areas of low or high density are near the region being scanned.

Multi-voxel, 2D CSI MRS is more accurate than the single-voxel form because the chemical scan is made from two different angles, allowing multiple small areas of tissue to be analyzed individually. Single-voxel scans are created by averaging the chemical signatures from a broader area, which means that tumor tissue and nearby dying tissue might be considered together. Multi-voxel scanning also allows radiologists to look at the tissue in a variety of locations inside and outside the original tumor area -- possibly revealing new tumor growth that isn’t yet visible on a regular MRI.

"All in all, the likelihood of picking up a recurrence is greater, and the chance that we’ll make an accurate, specific diagnosis is much higher, perhaps around 90 percent," says Weybright. "That means a patient can start a new round of treatment much earlier if the cancer is coming back, or avoid biopsies and unnecessary treatment, if the tissue is just inflamed or dying."

Kara Gavin | EurekAlert!
Further information:
http://www2.med.umich.edu/prmc/media/relarch.cfm

More articles from Studies and Analyses:

nachricht Statistical method developed at TU Dresden allows the detection of higher order dependencies
07.02.2020 | Technische Universität Dresden

nachricht Novel study underscores microbial individuality
13.12.2019 | Bigelow Laboratory for Ocean Sciences

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

Im Focus: Quantum fluctuations sustain the record superconductor

Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected

Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Movement of a liquid droplet generates over 5 volts of electricity

18.02.2020 | Power and Electrical Engineering

Powering the future: Smallest all-digital circuit opens doors to 5 nm next-gen semiconductor

18.02.2020 | Information Technology

Studying electrons, bridging two realms of physics: connecting solids and soft matter

18.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>